SciSight Ecosystem
WoS SCIE Q1SCImago #32,178CAS 1区Top JournalHybrid

Theranostics

Abbreviation (ISO):THERANOSTICS
Country: Australia•WoS SCIE Quartile: Q1•SCImago Rank: #32,178•Identifier (ISSN):1838-7640(Print)•Articles / Year: 605•Estimated Publication Fee (APC): $3,993 USD
Clarivate IF (2026)Q1
14.9
↑ +1.6

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
69

69 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
605articles/year
99.92% Gold OA•80.51% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 14.9)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 14.9)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 13.3)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 12.4)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 12.4)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 11.6)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 11.556)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.579)
🔵 Computed
20193.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.063)
🔵 Computed
20183.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.537)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications

Topics Covered (Recognized by AI)
Biology96.8%Medicine93.5%Genetics88.8%Chemistry87.6%Internal medicine78.4%Biochemistry76.2%Cancer research50.8%Gene39.6%Physics39.1%Cell biology38%Cancer37.6%Pathology35.8%Immunology33.8%Organic chemistry31.1%Materials science29.3%Biotechnology24.9%Engineering23.7%In vivo23.4%Nanotechnology23.1%Psychology23.1%Endocrinology22.5%Quantum mechanics21.3%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #32,178SCImago Profile
Scopus Coverage:2011-2025
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)
—

Weighted prestige citation metric per document indexed in the Scopus database.

Đã chuẩn hóa dữ liệu
Scopus H-Index (2025)
199

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
14.16

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,993 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations18,471
3-Year Documents1,199
Citable Documents1,199

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)—
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)—

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Ivyspring International Publisher
Publication Language
English
Frequency
Periodic
Founding Year
2011
Editorial Address
PO BOX 4546, LAKE HAVEN, AUSTRALIA, NSW, 2263
Indexing & Databases
SCIEScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
MEDICINE, RESEARCH & EXPERIMENTAL
JCRSCIE
6/191Q1
MEDICINE, RESEARCH & EXPERIMENTAL
JCISCIE
4/191Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—289392
202513.35715,766
202412.445812,044
202312.433214,388
202211.644825,629
202111.55653441,423
20208.57987174,317
20198.06361353,973
20188.53741339,197
2017—39937,382
2016—19720,880
2015—11912,439
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Theranostics

WoS Q1
5912162018201920202021202220232024202513.30
Annual Impact Factor Metric
2025:13.3

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

MedComm
IF: 14.1Q1
99% MatchExplore →
Med
IF: 13.3Q1
99% MatchExplore →
Record UUID: 02f48f15-208b-4e61-8d7f-190688a900ec
Database Updated: 2026-10-01